.Adhering to an unsatisfactory showing for Lykos Therapeutics' MDMA prospect for trauma at a recent ...
.AN2 Therapies is reconsidering its own service in action to dull midphase records, vowing to lay of...
.Merck & Co. is paying out $700 million beforehand to test Amgen in a blood stream cancer market....
.With Gilead Sciences about to an FDA decision for its liver disease medication seladelpar, the prov...
.CEO David Ricks may see the business setting up camping tents at basecamp behind Eli Lilly in an ef...
.Mattress Liquidators has actually turned Entero Therapeutics white colored as a piece. The collecto...
.Exelixis is giving up on its own tissue element (TF)- targeting antibody-drug conjugate after endin...
.3 full weeks after Roche's Genentech device ignored an SHP2 prevention deal, Relay Therapy has conf...
.Stoke Rehabs' Dravet syndrome medication has actually been devoid of a partial hold, getting rid of...
.Strong Biotech Colleague Editor Gabrielle Masson provided the 2024 course of Strong 15 winners on t...